Gaurav Aggarwal, Managing Partner, Vivo Capital "Breaking Into—and Leading—Life Sciences Investing"

Dr. Gaurav Aggarwal, Managing Partner at Vivo Capital, shares his journey from earning an MD from Columbia University to becoming a leading figure in life sciences investing. Despite initial family pressure to pursue medicine, Aggarwal found the clinical practice unfulfilling and pivoted to finance after a serendipitous opportunity at a boutique investment bank. His medical training became a 'superpower' in evaluating biotech investments, allowing him to dig deeper into scientific data than most investors. He reflects on pivotal career moments, including a contrarian investment in Auspex Pharmaceuticals that led to a billion-dollar exit, and a transformative three-year stint as Chief Business Officer at Ocera Therapeutics, which deepened his empathy for entrepreneurs. At Vivo Capital, he helped expand the firm’s strategy beyond venture capital into public equities, growth equity, and private equity, emphasizing the importance of independent thinking and long-term conviction. Aggarwal highlights exciting frontiers in targeted oncology, autoimmune disease, and neurodegenerative therapies, while underscoring Vivo’s global approach—leveraging expertise in both U.S. and Asian markets despite geopolitical tensions. He closes with a call to action for listeners to engage with AIM’s events and network-building initiatives. The episode underscores a powerful narrative about breaking the bamboo ceiling through unconventional paths, resilience, and intellectual courage. Key takeaways include the value of diverse backgrounds in investing, the importance of learning from failure, the power of contrarian thinking in high-risk, high-reward sectors like biotech, and the necessity of building global networks in innovation-driven industries. Aggarwal’s story exemplifies how personal passion, combined with strategic risk-taking and deep domain expertise, can create lasting impact in the investment world.